Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux

ACS Nano

Volumn 6, Issue 1, 2012, Pages 276-285

  Luthi, Andrea J ^a   Zhang, Heng ^b   Kim, Dongwoo ^a   Giljohann, David A ^a   Mirkin, Chad A ^a,c   Thaxton, C Shad ^a,b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

atherosclerosis; biomimic; cholesterol efflux; gold; high density lipoprotein; nanoparticle

Indexed keywords

ATHEROSCLEROSIS; BINDING PROPERTIES; BIOMIMIC; CHOLESTEROL EFFLUX; DIFFERENT SIZES; GOLD NANOPARTICLE; HIGH-DENSITY LIPOPROTEINS; MACROPHAGE CELLS; PHYSICAL CHARACTERISTICS;

BINDING ENERGY; BIOMIMETICS; CHOLESTEROL; GOLD ALLOYS; MACROPHAGES; NANOPARTICLES; SURFACE CHEMISTRY;

GOLD;

BIOMIMETIC MATERIAL; CHOLESTEROL; GOLD; HIGH DENSITY LIPOPROTEIN; NANOSPHERE;

ARTICLE; CHEMISTRY; CONFORMATION; CRYSTALLIZATION; DIFFUSION; MACROMOLECULE; MATERIALS TESTING; METHODOLOGY; PARTICLE SIZE; PROTEIN BINDING; SURFACE PROPERTY; ULTRASTRUCTURE;

BIOMIMETIC MATERIALS; CHOLESTEROL; CRYSTALLIZATION; DIFFUSION; GOLD; LIPOPROTEINS, HDL; MACROMOLECULAR SUBSTANCES; MATERIALS TESTING; MOLECULAR CONFORMATION; NANOSPHERES; PARTICLE SIZE; PROTEIN BINDING; SURFACE PROPERTIES;

EID: 84856189299     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn2035457     Document Type: Article

References (58)

1. Mackay, J.; Mensah, G. A. Atlas of Heart Disease and Stroke; World Health Organization and Centers for Disease Control and Prevention, 2004.
2. Falk, E. Pathogenesis of Atherosclerosis J. Am. Coll. Cardiol. 2006, 47, C7-C12
3. Genest, J.; Libby, P. Lipoprotein Disorders and Cardiovascular Disease. In Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine [Online], 9 th ed.; Bonow, R. O.; Mann, D. L.; Zipes, D. P.; Libby, P., Eds; Elsevier Saunders: Philadelphia, PA, 2011; pp 975-994; http://www.mdconsult.com.ezproxy. galter.northwestern.edu/books/page.do?eid=4-u1.0-B978-1-4377-0398-6. 00047-0&isbn=978-1-4377-0398-6&uniqId=303440482-2#4-u1. 0-B978-1-4377-0398-6.00047-0 (accessed August 8, 2011).
4. Glass, C. K.; Witztum, J. L. Atherosclerosis: The Road Ahead Cell 2001, 104, 503-516
5. Lusis, A. J. Atherosclerosis Nature 2000, 407, 233-241
6. Singh, I. M.; Shishehbor, M. H.; Ansell, B. J. High-Density Lipoprotein as a Therapeutic Target: A Systematic Review JAMA, J. Am. Med. Assoc. 2007, 298, 786-798
7. Gordon, T.; Castelli, W. P.; Hjortland, M. C.; Kannel, W. B.; Dawber, T. R. High-Density Lipoprotein as a Protective Factor against Coronary Heart-Disease-Framingham Study Am. J. Med. 1977, 62, 707-714
8. Calabresi, L.; Gomaraschi, M.; Rossoni, G.; Franceschini, G. Synthetic High Density Lipoproteins for the Treatment of Myocardial Ischemia/Reperfusion Injury Pharmacol. Ther. 2006, 111, 836-854
9. Ikonen, E. Cellular Cholesterol Trafficking and Compartmentalization Nat. Rev. Mol. Cell Biol. 2008, 9, 125-138
10. Nissen, S. E.; Tsunoda, T.; Tuzcu, E. M.; Schoenhagen, P.; Cooper, C. J.; Yasin, M.; Eaton, G. M.; Lauer, M. A.; Sheldon, W. S.; Grines, C. L. et al. Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients with Acute Coronary Syndromes: A Randomized Controlled Trial JAMA, J. Am. Med. Assoc. 2003, 290, 2292-2300
11. Nicholls, S. J.; Uno, K.; Kataoka, Y.; Nissen, S. E. ETC-216 for Coronary Artery Disease Expert Opin. Biol. Ther. 2011, 11, 387-394
12. Jonas, A. Reconstitution of High-Density-Lipoproteins Methods Enzymol. 1986, 128, 553-582
13. Silva, R. A. G. D.; Huang, R.; Morris, J.; Fang, J.; Gracheva, E. O.; Ren, G.; Kontush, A.; Jerome, W. G.; Rye, K. A.; Davidson, W. S. Structure of Apolipoprotein A-I in Spherical High Density Lipoproteins of Different Sizes Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 12176-12181
14. Wang, M. H.; Briggs, M. R. HDL: The Metabolism, Function, and Therapeutic Importance Chem. Rev. 2004, 104, 119-137
15. Davidson, W. S.; Thompson, T. B. The Structure of Apolipoprotein A-I in High Density Lipoproteins J. Biol. Chem. 2007, 282, 22249-22253
16. Thomas, M. J.; Bhat, S.; Sorci-Thomas, M. G. Three-Dimensional Models of HDL ApoA-I: Implications for Its Assembly and Function J. Lipid Res. 2008, 49, 1875-1883
17. Huang, R.; Silva, R. A. G. D.; Jerome, W. G.; Kontush, A.; Chapman, M. J.; Curtiss, L. K.; Hodges, T. J.; Davidson, W. S. Apolipoprotein A-1 Structural Organization in High-Density Lipoproteins Isolated from Human Plasma Nat. Struct. Mol. Biol. 2011, 18, 416-423
18. Asztalos, B. F.; Tani, M.; Schaefer, E. J. Metabolic and Functional Relevance of HDL Subspecies Curr. Opin. Lipidol. 2011, 22, 176-185
19. Asztalos, B. F.; Cupples, L. A.; Demissie, S.; Horvath, K. V.; Cox, C. E.; Batista, M. C.; Schaefer, E. J. High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study Arterioscler., Thromb., Vasc. Biol. 2004, 24, 2181-2187
20. Asztalos, B. F.; Collins, D.; Cupples, L. A.; Demissie, S.; Horvath, K. V.; Bloomfield, H. E.; Robins, S. J.; Schaefer, E. J. Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial Arterioscler., Thromb., Vasc. Biol. 2005, 25, 2185-2191
21. Movva, R.; Rader, D. J. Laboratory Assessment of HDL Heterogeneity and Function Clin. Chem. 2008, 54, 788-800
22. Daniel, M. C.; Astruc, D. Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum-Size-Related Properties, and Applications toward Biology, Catalysis, and Nanotechnology Chem. Rev. 2004, 104, 293-346
23. Mirkin, C. A.; Letsinger, R. L.; Mucic, R. C.; Storhoff, J. J. A DNA-Based Method for Rationally Assembling Nanoparticles into Macroscopic Materials Nature 1996, 382, 607-609
24. Elghanian, R.; Storhoff, J. J.; Mucic, R. C.; Letsinger, R. L.; Mirkin, C. A. Selective Colorimetric Detection of Polynucleotides Based on the Distance-Dependent Optical Properties of Gold Nanoparticles Science 1997, 277, 1078-1081
25. Rosi, N. L.; Giljohann, D. A.; Thaxton, C. S.; Lytton-Jean, A. K. R.; Han, M. S.; Mirkin, C. A. Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation Science 2006, 312, 1027-1030
26. Lee, J. S.; Lytton-Jean, A. K. R.; Hurst, S. J.; Mirkin, C. A. Silver Nanoparticle-Oligonucleotide Conjugates Based on DNA with Triple Cyclic Disulfide Moieties Nano Lett. 2007, 7, 2112-2115
27. Giljohann, D. A.; Seferos, D. S.; Daniel, W. L.; Massich, M. D.; Patel, P. C.; Mirkin, C. A. Gold Nanoparticles for Biology and Medicine Angew. Chem., Int. Ed. 2010, 49, 3280-3294
28. Cutler, J. I.; Zheng, D.; Xu, X. Y.; Giljohann, D. A.; Mirkin, C. A. Polyvalent Oligonucleotide Iron Oxide Nanoparticle "Click" Conjugates Nano Lett. 2010, 10, 1477-1480
29. Cutler, J. I.; Zhang, K.; Zheng, D.; Auyeung, E.; Prigodich, A. E.; Mirkin, C. A. Polyvalent Nucleic Acid Nanostructures J. Am. Chem. Soc. 2011, 133, 9254-9257
30. Feldherr, C. M.; Lanford, R. E.; Akin, D. Signal-Mediated Nuclear Transport in Simian-Virus 40-Transformed Cells Is Regulated by Large Tumor-Antigen Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 11002-11005
31. El-Sayed, I. H.; Huang, X. H.; El-Sayed, M. A. Surface Plasmon Resonance Scattering and Absorption of Anti-EGFR Antibody Conjugated Gold Nanoparticles in Cancer Diagnostics: Applications in Oral Cancer Nano Lett. 2005, 5, 829-834
32. Kim, Y. P.; Daniel, W. L.; Xia, Z. Y.; Xie, H. X.; Mirkin, C. A.; Rao, J. H. Bioluminescent Nanosensors for Protease Detection Based upon Gold Nanoparticle-Luciferase Conjugates Chem. Commun. 2010, 46, 76-78
33. Xie, H.; Tkachenko, A. G.; Glomm, W. R.; Ryan, J. A.; Brennaman, M. K.; Papanikolas, J. M.; Franzen, S.; Feldheim, D. L. Critical Flocculation Concentrations, Binding Isotherms, and Ligand Exchange Properties of Peptide-Modified Gold Nanoparticles Studied by UV-Visible, Fluorescence, and Time-Correlated Single Photon Counting Spectroscopies Anal. Chem. 2003, 75, 5797-5805
34. Patel, P. C.; Giljohann, D. A.; Seferos, D. S.; Mirkin, C. A. Peptide Antisense Nanoparticles Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 17222-17226
35. Corbierre, M. K.; Cameron, N. S.; Sutton, M.; Mochrie, S. G. J.; Lurio, L. B.; Ruhm, A.; Lennox, R. B. Polymer-Stabilized Gold Nanoparticles and Their Incorporation into Polymer Matrices J. Am. Chem. Soc. 2001, 123, 10411-10412
36. Raula, J.; Shan, J.; Nuopponen, M.; Niskanen, A.; Jiang, H.; Kauppinen, E. I.; Tenhu, H. Synthesis of Gold Nanoparticles Grafted with a Thermoresponsive Polymer by Surface-Induced Reversible-Addition-Fragmentation Chain-Transfer Polymerization Langmuir 2003, 19, 3499-3504
37. Thaxton, C. S.; Daniel, W. L.; Giljohann, D. A.; Thomas, A. D.; Mirkin, C. A. Templated Spherical High Density Lipoprotein Nanoparticles J. Am. Chem. Soc. 2009, 131, 1384-1385
38. Cormode, D. P.; Skajaa, T.; van Schooneveld, M. M.; Koole, R.; Jarzyna, P.; Lobatto, M. E.; Calcagno, C.; Barazza, A.; Gordon, R. E.; Zanzonico, P. et al. Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform Nano Lett. 2008, 8, 3715-3723
39. Cormode, D. P.; Roessl, E.; Thran, A.; Skajaa, T.; Gordon, R. E.; Schlomka, J. P.; Fuster, V.; Fisher, E. A.; Mulder, W. J. M.; Proksa, R. et al. Atherosclerotic Plaque Composition: Analysis with Multicolor CT and Targeted Gold Nanoparticles Radiology 2010, 256, 774-782
40. Skajaa, T.; Zhao, Y. M.; van den Heuvel, D. J.; Gerritsen, H. C.; Cormode, D. P.; Koole, R.; van Schooneveld, M. M.; Post, J. A.; Fisher, E. A.; Fayad, Z. A. et al. Quantum Dot and Cy5.5 Labeled Nanoparticles To Investigate Lipoprotein Biointeractions via Forster Resonance Energy Transfer Nano Lett. 2010, 10, 5131-5138
41. Skajaa, T.; Cormode, D. P.; Jarzyna, P. A.; Delshad, A.; Blachford, C.; Barazza, A.; Fisher, E. A.; Gordon, R. E.; Fayad, Z. A.; Mulder, W. J. M. The Biological Properties of Iron Oxide Core High-Density Lipoprotein in Experimental Atherosclerosis Biomaterials 2011, 32, 206-213
42. McMahon, K. M.; Mutharasan, R. K.; Tripathy, S.; Veliceasa, D.; Bobeica, M.; Shumaker, D. K.; Luthi, A. J.; Helfand, B. T.; Ardehali, H.; Mirkin, C. A. et al. Biomimetic High Density Lipoprotein Nanoparticles for Nucleic Acid Delivery Nano Lett. 2011, 11, 1208-1214
43. Warnick, G. R.; McNamara, J. R.; Boggess, C. N.; Clendenen, F.; Williams, P. T.; Landolt, C. C. Polyacrylamide Gradient Gel Electrophoresis of Lipoprotein Subclasses Clin. Lab. Med. 2006, 26, 803-846
44. Brust, M.; Walker, M.; Bethell, D.; Schiffrin, D. J.; Whyman, R. Synthesis of Thiol-Derivatized Gold Nanoparticles in a 2-Phase Liquid-Liquid System J. Chem. Soc., Chem. Commun. 1994, 801-802
45. Mimms, L. T.; Zampighi, G.; Nozaki, Y.; Tanford, C.; Reynolds, J. A. Phospholipid Vesicle Formation and Transmembrane Protein Incorporation Using Octyl Glucoside Biochemistry 1981, 20, 833-840
46. Hatziantoniou, S.; Nezis, I. P.; Margaritis, L. H.; Demetzos, C. Visualisation of Liposomes Prepared from Skin and Stratum Corneum Lipids by Transmission Electron Microscopy Micron 2007, 38, 777-781
47. Jonas, A.; Phillips, M. C. Lipoprotein Structure. In Biochemistry of Lipids, Lipoproteins and Membranes, 5 th ed.; Vance, D. E.; Vance, J. E., Eds.; Elsevier B.V.: Amsterdam, 2008; pp 485-506.
48. Segrest, J. P.; Jones, M. K.; De Loof, H.; Brouillette, C. G.; Venkatachalapathi, Y. V.; Anantharamaiah, G. M. The Amphipathic Helix in the Exchangeable Apolipoproteins: A Review of Secondary Structure and Function J. Lipid Res. 1992, 33, 141-166
49. Chattopadhyay, A. Chemistry and Biology of N -(7-Nitrobenz-2-oxa-1,3- diazol-4-yl)-Labeled Lipids-Fluorescent-Probes of Biological and Model Membranes Chem. Phys. Lipids 1990, 53, 1-15
50. Tetin, S. Y.; Hazlett, T. L. Optical Spectroscopy in Studies of Antibody-Hapten Interactions Methods 2000, 20, 341-361
51. Avdulov, N. A.; Chochina, S. V.; Igbavboa, U.; Warden, C. S.; Schroeder, F.; Wood, W. G. Lipid Binding to Sterol Carrier Protein-2 Is Inhibited by Ethanol Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 1999, 1437, 37-45
52. Waddington, E. I.; Boadu, E.; Francis, G. A. Cholesterol and Phospholipid Efflux from Cultured Cells Methods 2005, 36, 196-206
53. Fiévet, C.; Staels, B. Lixer X Receptor Modulators: Effects on Lipid Metabolism and Potential Use in the Treatment of Atherosclerosis Biochem. Pharmacol. 2009, 77, 1316-1327
54. Frank, P. G.; Marcel, Y. L. Apolipoprotein A-I: Structure-Function Relationships J. Lipid Res. 2000, 41, 853-872
55. Duong, M.; Collins, H. L.; Jin, W. J.; Zanotti, I.; Favari, E.; Rothblat, G. H. Relative Contributions of ABCA1 and SR-BI to Cholesterol Efflux to Serum from Fibroblasts and Macrophages Arterioscler., Thromb., Vasc. Biol. 2006, 26, 541-547
56. Mendez, A. J. Cholesterol Efflux Mediated by Apolipoproteins Is an Active Cellular Process Distinct from Efflux Mediated by Passive Diffusion J. Lipid Res. 1997, 38, 1807-1821
57. Coyle, L. C.; Danilov, Y. N.; Juliano, R. L.; Regen, S. L. Chemisorbed Phospholipid Monolayers on Gold: Well-Defined and Stable Phospholipid Surfaces for Cell Adhesion Studies Chem. Mater. 1989, 1, 606-611
58. Jue, R.; Lambert, J. M.; Pierce, L. R.; Traut, R. R. Addition of Sulfhydryl Groups to Escherichia coli Ribosomes by Protein Modification with 2-Iminothiolane (Methyl 4-Mercaptobutyrimidate) Biochemistry 1978, 17, 5399-5406